IXICO Chairman, Andy Richards, Receives CBE

Andy Richards, IXICO’s Chairman, receives a CBE in the Queen’s Birthday Honours for services to Investment in the Life Sciences Industry.

Andy was appointed chairman of IXICO in 2009. He is an established life science entrepreneur with experience in growing businesses, corporate transactions and exits. Currently Andy is the chairman of Altacor, Abcodia, Congenica and Novacta, as well as a director of Arecor Limited, Psychologyonline.co.uk Limited, Cancer Research Technology Limited (commercial arm of CR-UK) and Babraham Bioscience Technologies Limited. Andy is also a director of Cambridge University Health Trust and an adviser to Vectura Group plc.

Andy’s early career was with ICI (now AstraZeneca) and with PA Technology. He was a founder of Chiroscience Group PLC and an executive director through to the sale to Celltech Group PLC in 1999. Since that time he has been founding, investing in and directing new UK healthcare and life science companies. Andy is a graduate of Cambridge University with a PhD in Chemistry.
For full details on IXICO’s board please click here.

By |2017-10-11T15:53:32+00:0015 June 2015|IXICO|